Abstract
Dr Hope S. Rugo presents a real-world evaluation of overall survival with palbociclib plus aromatase inhibitor in patients with HR+/HER2- MBC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have